Related Experiment Video
Updated: Aug 25, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke
L Parnetti1, V Caso, A Santucci
1Department of Neuroscience, Stroke Unit, University of Perugia, Via Enrico dal Pozzo, I-06126 Perugia, Italy. parnetti@unipg.it
Insights
Elevated homocysteine levels are confirmed as an independent risk factor for all stroke types. Routine measurement and treatment of hyperhomocysteinemia are recommended for stroke patients.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Clinical Chemistry
Background:
- Hyperhomocysteinemia is a potential independent risk factor for stroke.
- Confirmation of its role and interaction with conventional risk factors is needed.
Purpose of the Study:
- To assess the association between plasma homocysteine levels and stroke risk.
- To investigate the interaction between mild hyperhomocysteinemia and conventional vascular risk factors.
Main Methods:
- 161 first-ever ischemic stroke patients (TOAST criteria) and 152 healthy controls were studied.
- Plasma homocysteine levels were measured using high-performance liquid chromatography (HPLC).
- Logistic regression analysis was employed to identify independent risk factors.
Main Results:
- Mean homocysteine levels were significantly higher in stroke patients (13.0-17.8 micromol/l) compared to controls (8.10 micromol/l).
- Hyperhomocysteinemia was an independent risk factor across all stroke subtypes.
- Hypertension (OR=3.205) and hyperlipidemia (OR=2.243) were also significant independent risk factors.
Conclusions:
- Hyperhomocysteinemia is an independent risk factor for all stroke subtypes.
- Routine measurement and treatment of hyperhomocysteinemia should be considered in stroke patients.
Abstract:
The role of hyperhomocysteinemia as independent risk factor for stroke needs to be confirmed. The aims of our study were to assess (i) the association between risk of stroke and increasing values of plasma homocysteine and (ii) the interaction between mild hyperhomocysteinemia and conventional vascular risk factors. We studied 161 consecutive patients with first-ever ischemic stroke classified using TOAST criteria and 152 neurologically healthy controls. Homocysteine was measured using high performance liquid chromatography (HPLC). Homocysteinemia was elevated in all stroke subtypes: 13.0+/-2.5 micromol/l in patients with cardioembolic disease, 13.9+/-5.4 micromol/l in those with small vessel diseases, 15.5+/-6.8 micromol/l in cases of undetermined stroke, and 17.8+/-13.5 micromol/l in patients with large vessel disease. Mean homocysteinemia was 8.10 micromol/l (SD=2.5) in controls. The logistic regression analysis showed that important independent risk factors for ischemic stroke were hypertension (p<0.0001; OR= 3.205; 95% CI, 1.788-5.742), hyperhomocysteinemia (p<0.0001; OR=1.425; 95% CI, 1.300-1562) and hyperlipidemia (p=0.018; OR=2.243; 95% CI, 1.147-4.385). Hyperhomocyst(e)inemia is an independent risk factor for all stroke subtypes and should be routinely measured and treated in stroke patients.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Stroke: Introduction and Types
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...